{"id":33025,"date":"2021-04-22T01:38:00","date_gmt":"2021-04-21T23:38:00","guid":{"rendered":"https:\/\/www.ipsen.com\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/"},"modified":"2024-07-22T10:45:06","modified_gmt":"2024-07-22T08:45:06","slug":"croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/","title":{"rendered":"Croissance des ventes encourageante lors du premier trimestre 2021 malgr\u00e9 l\u2019impact de la pand\u00e9mie; objectifs financiers annuels confirm\u00e9s pour 2021"},"content":{"rendered":"<p><strong>Paris (France), le 22 avril 2021&nbsp;<\/strong>\u2013 Ipsen (Euronext : IPN ; ADR : IPSEY), groupe biopharmaceutique mondial de sp\u00e9cialit\u00e9, publie aujourd\u2019hui son chiffre d\u2019affaires Groupe pour le premier trimestre 2021.<\/p>\n<p><strong>Synth\u00e8se des ventes r\u00e9alis\u00e9es au premier trimestre 2021<\/strong>&nbsp;(Chiffre d\u2019affaires consolid\u00e9 IFRS non audit\u00e9)<\/p>\n<p>&nbsp;<\/p>\n<table style=\"border-collapse: collapse;width:811px;border-collapse:collapse\">\n<tbody>\n<tr>\n<td rowspan=\"2\" style=\"width:239px;text-align: center;vertical-align: middle\"><em><strong>&nbsp;<\/strong><\/em><\/td>\n<td style=\"width:166px;text-align: center;vertical-align: middle\">&nbsp;<\/td>\n<td colspan=\"2\" style=\"width:691px;text-align: center;vertical-align: middle\"><strong>1er trimestre 2021<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width:166px;text-align: center;vertical-align: middle\"><strong>(en millions d\u2019euros)<\/strong><\/td>\n<td colspan=\"2\" style=\"width:691px;text-align: center;vertical-align: middle;text-align: center;vertical-align: middle;text-align: center;vertical-align: middle;text-align: center;vertical-align: middle\"> <strong>% variation<\/strong><br \/>\n<strong>\u00c0 donn\u00e9es&nbsp;<\/strong><strong>publi\u00e9es&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;\u00c0 taux de change constant<\/strong><strong>1<\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"width:239px\">&nbsp;<\/td>\n<td style=\"width:166px\">&nbsp;<\/td>\n<td style=\"width:243px\">&nbsp;<\/td>\n<td style=\"width:448px\">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td style=\"width:239px;text-align: center;vertical-align: middle\">M\u00e9decine de Sp\u00e9cialit\u00e9<\/td>\n<td style=\"width:166px;text-align: center;vertical-align: middle\">611,5<\/td>\n<td style=\"width:243px;text-align: center;vertical-align: middle\">1,5<\/td>\n<td style=\"width:448px;text-align: center;vertical-align: middle\">6,4<\/td>\n<\/tr>\n<tr>\n<td style=\"width:239px;text-align: center;vertical-align: middle\">Sant\u00e9 Familiale<\/td>\n<td style=\"width:166px;text-align: center;vertical-align: middle\">47,0<\/td>\n<td style=\"width:243px;text-align: center;vertical-align: middle\">-9,6<\/td>\n<td style=\"width:448px;text-align: center;vertical-align: middle\">-5,4<\/td>\n<\/tr>\n<tr>\n<td style=\"width:239px;text-align: center;vertical-align: middle\"><strong>Chiffre d\u2019affaires Groupe<\/strong><\/td>\n<td style=\"width:166px;text-align: center;vertical-align: middle\"><strong>658,5<\/strong><\/td>\n<td style=\"width:243px;text-align: center;vertical-align: middle\"><strong>0,6<\/strong><\/td>\n<td style=\"width:448px;text-align: center;vertical-align: middle\"><strong>5,5<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<ul>\n<li style=\"margin-bottom:3px\">Croissance du chiffre d\u2019affaires Groupe de 5,5 % \u00e0 taux de change constant (ventes publi\u00e9es en hausse de 0,6 %) au premier trimestre 2021, \u00e0 658,5 millions d\u2019euros, malgr\u00e9 l\u2019impact de la pand\u00e9mie.<\/li>\n<li style=\"margin-bottom:3px\">Croissance de 6,4 %<sup>1<\/sup> &nbsp;des ventes de produits de M\u00e9decine de Sp\u00e9cialit\u00e9 \u00e0 611,5 millions d\u2019euros, tir\u00e9es par la croissance des ventes de Cabometyx\u00ae&nbsp;(<em>cabozantinib<\/em>), D\u00e9capeptyl\u00ae&nbsp;(<em>triptor\u00e9line<\/em>), Somatuline\u00ae&nbsp;(lanreotide) et Dysport\u00ae&nbsp;(<em>toxine botulique de type A<\/em>).<\/li>\n<li style=\"margin-bottom:3px\">Baisse des ventes en Sant\u00e9 Familiale de 5,4 %<sup>1<\/sup> \u00e0 47,0 millions d\u2019euros, refl\u00e9tant les effets persistants de la pand\u00e9mie de la COVID-19, partiellement compens\u00e9e par la reprise en Chine.<\/li>\n<li style=\"margin-bottom:3px\">Approbation par la Commission europ\u00e9enne de Cabometyx\u00ae&nbsp;en association avec le nivolumab comme traitement en premi\u00e8re ligne pour les patients atteints d\u2019un carcinome r\u00e9nal avanc\u00e9.<\/li>\n<li style=\"margin-bottom:3px\">Confirmation des objectifs financiers pour 2021.&nbsp;<strong>&nbsp;<\/strong><\/li>\n<\/ul>\n<p><strong>David Loew, Directeur g\u00e9n\u00e9ral d\u2019Ipsen, a d\u00e9clar\u00e9 :<\/strong><br \/>\n\u00ab<em>&nbsp;Nous avons r\u00e9alis\u00e9 une solide performance au cours de ce trimestre, malgr\u00e9 un environnement particuli\u00e8rement difficile li\u00e9 \u00e0 la COVID-19 gr\u00e2ce \u00e0 notre focalisation constante sur les patients.<\/em>&nbsp;<em>Nos r\u00e9sultats sont en ad\u00e9quation avec notre strat\u00e9gie et nos objectifs financiers pour l\u2019exercice.<\/em>&nbsp;<em>Les produits d\u2019Ipsen en Oncologie se sont d\u00e9marqu\u00e9s sur la p\u00e9riode. L\u2019approbation r\u00e9glementaire en Europe de Cabometyx<\/em>\u00ae<em>&nbsp;en association avec le nivolumab dans le carcinome r\u00e9nal avanc\u00e9 en premi\u00e8re ligne est la premi\u00e8re \u00e9tape d\u2019un lancement important pour le Groupe.<\/em>&nbsp;<em>L\u2019enregistrement anticip\u00e9 d\u2019un g\u00e9n\u00e9rique du lanr\u00e9otide sur le march\u00e9 europ\u00e9en est en ligne avec nos pr\u00e9visions.<\/em><\/p>\n<p><em>\u00c0 court terme, nous attendons les r\u00e9sultats de l\u2019\u00e9tude clinique \u00e9valuant Cabometyx<\/em>\u00ae<em>&nbsp;en association avec l\u2019atezolizumab dans le cancer du foie en premi\u00e8re ligne, ainsi que les avanc\u00e9es du palovarot\u00e8ne dans son processus d\u2019approbation r\u00e9glementaire. Nous poursuivons avec d\u00e9termination nos ambitions de renforcer notre portefeuille de produits en R&amp;D et de g\u00e9n\u00e9rer une croissance p\u00e9renne, constamment guid\u00e9s par notre strat\u00e9gie centr\u00e9e sur les patients. Je suis fier de l\u2019excellent travail r\u00e9alis\u00e9 par nos collaborateurs malgr\u00e9 les conditions difficiles li\u00e9es \u00e0 la pand\u00e9mie auxquelles font face nos \u00e9quipes \u00e0 travers le monde.&nbsp;&nbsp;<\/em>\u00bb<\/p>\n<p><strong>Objectifs financiers pour 2021<\/strong><br \/>\nLe Groupe r\u00e9it\u00e8re aujourd\u2019hui ses objectifs financiers pour l\u2019exercice 2021 ; ils int\u00e8grent l\u2019hypoth\u00e8se d\u2019une reprise progressive de l\u2019activit\u00e9 mondiale \u00e0 l\u2019issue de la crise provoqu\u00e9e par la pand\u00e9mie de la COVID-19 d\u2019ici le second semestre 2021. Ces objectifs int\u00e8grent \u00e9galement le lancement progressif d\u2019un g\u00e9n\u00e9rique de lanr\u00e9otide en Europe d\u2019ici-l\u00e0 mi-2021 et un impact limit\u00e9 li\u00e9 au lancement de g\u00e9n\u00e9riques de l\u2019octr\u00e9otide ou du lanr\u00e9otide aux \u00c9tats-Unis.<\/p>\n<p>&nbsp;<\/p>\n<table style=\"border-collapse: collapse;width:811px;border-collapse:collapse\">\n<tbody>\n<tr>\n<td style=\"width:239px;text-align: center;vertical-align: middle\">Ventes totales du Groupe<\/td>\n<td style=\"width:543px;text-align: center;vertical-align: middle\">Croissance sup\u00e9rieure \u00e0 4,0 % \u00e0 taux de change constant<\/td>\n<\/tr>\n<tr>\n<td style=\"width:239px;text-align: center;vertical-align: middle\">Marge op\u00e9rationnelle des activit\u00e9s<\/td>\n<td style=\"width:543px;text-align: center;vertical-align: middle\">Sup\u00e9rieure \u00e0 30,0 % des ventes, excluant l\u2019impact potentiel&nbsp; d\u2019investissements additionnels dans le cadre d\u2019innovation externe<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<p><strong>Effet de change<\/strong><br \/>\nIpsen anticipe un impact d\u00e9favorable des devises de l\u2019ordre de 2 % sur les ventes totales du Groupe pour l\u2019exercice 2021 sur la base des taux de change \u00e0 fin mars 2021.<\/p>\n<p><strong>Actualit\u00e9s sur le g\u00e9n\u00e9rique de Somatuline<\/strong>\u00ae<br \/>\nAu cours du trimestre, une r\u00e9ponse favorable a \u00e9t\u00e9 obtenue par l\u2019\u00c9tat membre de r\u00e9f\u00e9rence \u2013 le Danemark \u2013 et la proc\u00e9dure europ\u00e9enne d\u00e9centralis\u00e9e a \u00e9t\u00e9 close, pour une formulation g\u00e9n\u00e9rique de lanr\u00e9otide concernant les doses de 60mg, 90mg et 120mg. Des autorisations nationales de mise sur le march\u00e9 ont par ailleurs \u00e9t\u00e9 accord\u00e9es pour un g\u00e9n\u00e9rique du lanr\u00e9otide en France, au Danemark, en Hongrie et en Lettonie. Ces \u00e9volutions sont conformes aux pr\u00e9visions d\u2019Ipsen.<br \/>\n<strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;<\/strong><br \/>\n<strong>Business D\u00e9veloppement<\/strong><br \/>\nAu cours du premier trimestre, Ipsen et Fusion Pharmaceuticals Inc. ont conclu un accord d\u2019achat d\u2019actifs relatif \u00e0 l\u2019acquisition par Fusion Pharmaceuticals Inc. de la propri\u00e9t\u00e9 intellectuelle des actifs li\u00e9s \u00e0 l\u2019IPN-1087, une petite mol\u00e9cule en phase I de d\u00e9veloppement ciblant le r\u00e9cepteur de la neurotensine de sous-type 1 (NTSR1), une prot\u00e9ine exprim\u00e9e dans de nombreux types de tumeurs solides.<\/p>\n<p><strong>Conf\u00e9rence t\u00e9l\u00e9phonique<\/strong><br \/>\nUne conf\u00e9rence t\u00e9l\u00e9phonique et un webcast destin\u00e9s aux investisseurs et analystes se tiendront aujourd\u2019hui \u00e0 14h30, heure de Paris. Les participants pourront rejoindre la conf\u00e9rence quelques minutes plus t\u00f4t et peuvent s\u2019enregistrer&nbsp;<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LohznFJX7DwGI6zWHV7C_VoSNUu7ZkA0VLyJb_439WN2kk3cRv-m4fFdf4ZeGF36x-d_dnX_z0oox-6JeGgtguLziqGfXn7lcMblL1q3X9M=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><strong>ici<\/strong><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_fDMCqz1w1EMM8bznHCkbjgWMKcdWSFAeH3UP4XtMEJZZPRdgj7FAYmeQROMM04Y7mOoDzEhIRlth064cPgz1HMwBGn9DuhttvcYAM3dw0I=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><strong>.<\/strong><\/a>&nbsp;Pour acc\u00e9der au webcast, veuillez cliquer&nbsp;<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LohznFJX7DwGI6zWHV7C_Ysfc2yAasYoZe5ibbv2vBrJHJ1FLptOsH6FraRFAx-OfGIIaJOhJh-wbD7NE9OBwj6MVvkY2dzjIBfhxO4z0KE=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><strong>ici<\/strong><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DPhr3IbD3SIAa-rr5d_Dj9nqV2Deg1Z4sGTPplOI_jtqiK0ue3qZ6uXlAJfdEbYa5fRK3MofJg7La7XRhTD4MuoOXsjUzosnXhfD7KH2F6c=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><strong>.<\/strong><\/a><\/p>\n<p>Code d\u2019acc\u00e8s : 2495337.<\/p>\n<p>Une r\u00e9\u00e9coute sera disponible pendant 7 jours sur&nbsp;<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vmT59FzSInUfT2Jq-NOQdneDxLg6j_GvyE6qpgyCpnzaNUbl4GlDs6EgrSFVYwvnRMCruQysjU8nyITgWzdrbQ==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><strong>ipsen.com<\/strong><\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gnslQ-vO-rVbcbnnsD9WzUdG9dewFdcNyllv1VIKL6-ieyEIzNKxo00zmrCJIpYo\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><strong>.<\/strong><\/a><\/p>\n<p><strong>Calendrier<\/strong><br \/>\nLe Groupe pr\u00e9voit de publier ses r\u00e9sultats du premier semestre 2021 le 29 juillet 2021 et ses r\u00e9sultats pour le troisi\u00e8me trimestre le 21 octobre 2021. L\u2019Assembl\u00e9e g\u00e9n\u00e9rale des actionnaires se tiendra \u00e0 huit clos le 27 mai 2021.<\/p>\n<p><strong>Notes<\/strong><br \/>\nTous les chiffres financiers sont exprim\u00e9s en millions d\u2019euros. Sauf indication contraire, les performances publi\u00e9es dans ce communiqu\u00e9 couvrent la p\u00e9riode de trois mois courant du 1er janvier 2021 jusqu\u2019au 31 mars 2021 (le trimestre, le premier trimestre ou le 1er trimestre 2021), par rapport \u00e0 la p\u00e9riode de trois mois courant du 1er janvier 2020 jusqu\u2019au 31 mars 2020 (1er trimestre 2020) respectivement. Sauf indication contraire, les variations s\u2019expriment \u00e0 taux de change constant. Sauf indication contraire, les commentaires sur les performances se basent sur un taux de change constant.<\/p>\n<p>&nbsp;<\/p>\n<ol>\n<li style=\"margin-bottom:3px\">Variation \u00e0 taux de change constant, hors effets de change, \u00e9tabli en recalculant les performances de la p\u00e9riode consid\u00e9r\u00e9e sur la base des taux de change utilis\u00e9s pour la p\u00e9riode pr\u00e9c\u00e9dente.<\/li>\n<\/ol>\n<p id=\"gnw_attachments_section-header\">\n    <strong>Pi\u00e8ce jointe<\/strong><\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n        <a target=\"_blank\" href=\"https:\/\/www.globenewswire.com\/Tracker?data=s0BHO71YVIhVeet529HytKDd7IcwFsDwi2I91T4ldIJq3_hE-uUG3msibkXoH4JoeRHgvqWQ1bOdoZpPfCpGG4gEaPE11J2m5BVTL33nebG4fSsrjslRPENfhsjcl-S2xhyFRQIeRfqdTD-_w6nsqd83nCWtC8DsWDlY4ayRYkFIOUN59j62KClp6RRrDnY3KtmbqYe021B2S_wWrxGt2bR1izJRoQMYSHPq63dbPHs=\" title=\"Annonce-des-ventes-re\u0301alise\u0301es-au-premier-trimestre-2021\" rel=\"nofollow noopener\">Annonce-des-ventes-re\u0301alise\u0301es-au-premier-trimestre-2021<\/a><\/li>\n<\/ul>\n<p><img decoding=\"async\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/ZTIxYzQwMDMtZWFmZC00MzE1LWI0ODctNWJlNGI5NTE0M2YwLTEwMTA5NDM=\/tiny\/Ipsen-SA.png\"><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"template":"","categories":[1233,3556,3557],"tags":[],"class_list":["post-33025","press_release","type-press_release","status-publish","has-post-thumbnail","hentry","category-pressrelease-fr","category-corporate-pressrelease-fr","category-financial-pressrelease-fr","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Croissance des ventes encourageante lors du premier trimestre 2021 malgr\u00e9 l\u2019impact de la pand\u00e9mie; objectifs financiers annuels confirm\u00e9s pour 2021<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Croissance des ventes encourageante lors du premier trimestre 2021 malgr\u00e9 l\u2019impact de la pand\u00e9mie; objectifs financiers annuels confirm\u00e9s pour 2021\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:modified_time\" content=\"2024-07-22T08:45:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/28121356\/PR-final-fr.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1082\" \/>\n\t<meta property=\"og:image:height\" content=\"620\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/\"},\"author\":{\"name\":\"IPSEN\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0\"},\"headline\":\"Croissance des ventes encourageante lors du premier trimestre 2021 malgr\u00e9 l\u2019impact de la pand\u00e9mie; objectifs financiers annuels confirm\u00e9s pour 2021\",\"datePublished\":\"2021-04-21T23:38:00+00:00\",\"dateModified\":\"2024-07-22T08:45:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/\"},\"wordCount\":1086,\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/28121356\/PR-final-fr.jpg\",\"articleSection\":[\"Communiqu\u00e9 de presse\",\"Corporate\",\"Financier\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/\",\"url\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/\",\"name\":\"Croissance des ventes encourageante lors du premier trimestre 2021 malgr\u00e9 l\u2019impact de la pand\u00e9mie; objectifs financiers annuels confirm\u00e9s pour 2021\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/28121356\/PR-final-fr.jpg\",\"datePublished\":\"2021-04-21T23:38:00+00:00\",\"dateModified\":\"2024-07-22T08:45:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/#primaryimage\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/28121356\/PR-final-fr.jpg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/28121356\/PR-final-fr.jpg\",\"width\":1082,\"height\":620},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Croissance des ventes encourageante lors du premier trimestre 2021 malgr\u00e9 l\u2019impact de la pand\u00e9mie; objectifs financiers annuels confirm\u00e9s pour 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#website\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/www.ipsen.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0\",\"name\":\"IPSEN\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b569564123e1c5c4bb45b008fc273d5bfdd6464d8a8497307ebbe91af50ed000?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b569564123e1c5c4bb45b008fc273d5bfdd6464d8a8497307ebbe91af50ed000?s=96&d=mm&r=g\",\"caption\":\"IPSEN\"},\"sameAs\":[\"https:\/\/www.ipsen.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Croissance des ventes encourageante lors du premier trimestre 2021 malgr\u00e9 l\u2019impact de la pand\u00e9mie; objectifs financiers annuels confirm\u00e9s pour 2021","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/","og_locale":"fr_FR","og_type":"article","og_title":"Croissance des ventes encourageante lors du premier trimestre 2021 malgr\u00e9 l\u2019impact de la pand\u00e9mie; objectifs financiers annuels confirm\u00e9s pour 2021","og_url":"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/","og_site_name":"Global","article_modified_time":"2024-07-22T08:45:06+00:00","og_image":[{"width":1082,"height":620,"url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/28121356\/PR-final-fr.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@ipsengroup","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/#article","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/"},"author":{"name":"IPSEN","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0"},"headline":"Croissance des ventes encourageante lors du premier trimestre 2021 malgr\u00e9 l\u2019impact de la pand\u00e9mie; objectifs financiers annuels confirm\u00e9s pour 2021","datePublished":"2021-04-21T23:38:00+00:00","dateModified":"2024-07-22T08:45:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/"},"wordCount":1086,"publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/28121356\/PR-final-fr.jpg","articleSection":["Communiqu\u00e9 de presse","Corporate","Financier"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/","url":"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/","name":"Croissance des ventes encourageante lors du premier trimestre 2021 malgr\u00e9 l\u2019impact de la pand\u00e9mie; objectifs financiers annuels confirm\u00e9s pour 2021","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/28121356\/PR-final-fr.jpg","datePublished":"2021-04-21T23:38:00+00:00","dateModified":"2024-07-22T08:45:06+00:00","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/#primaryimage","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/28121356\/PR-final-fr.jpg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/28121356\/PR-final-fr.jpg","width":1082,"height":620},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/fr\/press-releases\/croissance-des-ventes-encourageante-lors-du-premier-trimestre-2021-malgre-limpact-de-la-pandemie-objectifs-financiers-annuels-confirmes-pour-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Croissance des ventes encourageante lors du premier trimestre 2021 malgr\u00e9 l\u2019impact de la pand\u00e9mie; objectifs financiers annuels confirm\u00e9s pour 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/fr\/#website","url":"https:\/\/www.ipsen.com\/fr\/","name":"Global","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/fr\/#organization","name":"IPSEN","url":"https:\/\/www.ipsen.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]},{"@type":"Person","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0","name":"IPSEN","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b569564123e1c5c4bb45b008fc273d5bfdd6464d8a8497307ebbe91af50ed000?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b569564123e1c5c4bb45b008fc273d5bfdd6464d8a8497307ebbe91af50ed000?s=96&d=mm&r=g","caption":"IPSEN"},"sameAs":["https:\/\/www.ipsen.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release\/33025","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release"}],"about":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/types\/press_release"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":4,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release\/33025\/revisions"}],"predecessor-version":[{"id":33249,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/press_release\/33025\/revisions\/33249"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media\/32792"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media?parent=33025"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/categories?post=33025"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/tags?post=33025"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}